Eyeworld

SEP 2022

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1475139

Contents of this Issue

Navigation

Page 4 of 90

Finally, an FDA-approved ophthalmic MMC. • USP <800> COMPLIANT 2 • FDA APPROVED FOR OPHTHALMOLOGY 3 THE TOTAL PACKAGE. • NO REFRIGERATION 1 Mitosol.com 1-877-393-6486 (877-EYE-MITO) • 24 MONTH SHELF LIFE AT ROOM TEMPERATURE 1 1. Data on file. 2. USP General Chapter <800> Hazardous Drugs - Handling in Healthcare Settings 3. Mitosol ® package insert. US Pat #7,806265, #8,186,511, D685,962, #9,205,075, #9,539,251, #9,649,428 Other US and International patents issued and/or pending UPGRADE YOUR STANDARD OF CARE M I T O S O L V E D. ™ 2021 004 © Mobius Therapeutics, LLC 2022

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SEP 2022